Nephros Announces Second Quarter 2020 Financial Results Conference Call
July 29 2020 - 7:30AM
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a
commercial-stage company that develops and sells water purification
products and pathogen detection systems to the medical and
commercial markets, today announced that it will file its second
quarter 2020 financial results on Wednesday, August 5, 2020
and will host a conference call that same day at 4:30 PM ET,
during which management will discuss the company's financial
results and provide a general business overview.
Participants may dial into the following number
to access the call: 1-844-808-7106. International callers may use
1-412-317-5285. Please ask to be joined into the Nephros conference
call. A replay of the call can be accessed until August 12, 2020 at
1-877-344-7529 or 1-412-317-0088 for international callers and
entering replay access code: 10144283. An audio archive of the call
will be available shortly after the call on the Nephros investor
relations page at https://investors.nephros.com/events/.
About Nephros:
Nephros is a commercial-stage company that
develops and markets high-performance water purification products
and pathogen detection systems for medical and commercial
markets.
Nephros ultrafilters are used in hospitals,
medical clinics, and commercial facilities to retain bacteria and
viruses from water, providing barriers that aid in infection
control for showers, sinks, and ice machines. Nephros ultrafilters
are also used in dialysis centers to aid in the removal of
endotoxins and other biological contaminants from water and
bicarbonate concentrate in hemodialysis machines.
Nephros pathogen detection systems, including
the PluraPath™ and SequaPath™ systems, provide near-real time
information on bacterial genera, waterborne bacteria, and viruses
to medical and water safety professionals. These products integrate
Nephros ultrafilters with DNA sequencing and quantitative
polymerase chain reaction (qPCR) technology.
Nephros commercial filters, including AETHER™
brand filters, improve the taste and odor of water, and reduce
scale build-up in downstream equipment. Nephros and AETHER™
products are used in the health care, food service, hospitality,
and convenience store markets.
For more information about Nephros, please visit
its website at www.nephros.com.
Investor Relations
Contact:Kirin Smith, PresidentPCG Advisory, Inc.(646)
863-6519ksmith@pcgadvisory.comwww.pcgadvisory.com
Media Contact: Bill Douglass Gotham
Communications, LLC (646) 504-0890
bill@gothamcomm.comwww.gothamcomm.com
Company Contact:Andy Astor, COO
& CFONephros, Inc.(201)
345-0824andy@nephros.comwww.nephros.com
Nephros (NASDAQ:NEPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nephros (NASDAQ:NEPH)
Historical Stock Chart
From Apr 2023 to Apr 2024